Cargando…
A Simple Chemical Method for Rendering Wild-Type Yeast Permeable to Brefeldin A That Does Not Require the Presence of an erg6 Mutation
The present work aims to develop a growth medium to render a wild-type strain of Saccharomyces cerevisiae permeable to the antifungal drug Brefeldin A. In the current study, a synthetic medium containing 0.1% L-proline and supplemented with 3.0 × 10(-3)% SDS is employed. When Brefeldin A is added to...
Autores principales: | Pannunzio, Vanesa G., Burgos, Hilda I., Alonso, Manuel, Mattoon, James R., Ramos, Eugenia H., Stella, Carlos A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551586/ https://www.ncbi.nlm.nih.gov/pubmed/15292581 http://dx.doi.org/10.1155/S1110724304308077 |
Ejemplares similares
-
Brefeldin a decreases the activity of the general amino acid permease (GAP1) and the more specific systems for L-leucine uptake in Saccharomyces cerevisiae
por: Alonso, Manuel, et al.
Publicado: (2006) -
Local translation of yeast ERG4 mRNA at the endoplasmic reticulum requires the brefeldin A resistance protein Bfr1
por: Manchalu, Srinivas, et al.
Publicado: (2019) -
Recent Synthesis and Discovery of Brefeldin A Analogs
por: Paek, Seung-Mann
Publicado: (2018) -
Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by brefeldin A
Publicado: (1991) -
The morphology but not the function of endosomes and lysosomes is altered by brefeldin A
Publicado: (1992)